Athersys and Pfizer Sign Global Stem Cell Agreement
By Taskin Ahmed
Pharma Deals Review: Vol 2010 Issue 1 (Table of Contents)
Published: 6 Jan-2010
DOI: 10.3833/pdr.v2010.i1.1301 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Pfizer and Athersys drew up a US$6 M global pact to develop and commercialise Multistem® for the treatment of inflammatory bowel disease (IBD)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS